During the past decade, READE conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "READE" #1 sponsor was "Pfizer" with 2 trials, followed by "Reade Rheumatology Research Institute" with 2 trials sponsored, "Amsterdam UMC, location VUmc" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "READE" #1 collaborator was "Sint Maartenskliniek" with 2 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 2 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Reade Rheumatology Research Institute" with 1 trials as a collaborator and "University Ghent" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "READE" are "Rheumatoid Arthritis" (5 trials), "Arthritis" (1 trials), "Cerebral Palsy, Spastic" (1 trials), "Osteoarthritis" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "READE" in a lesser frequency.

Most popular intervention types in "READE" are "Drug" (6 trials), "Biological" (3 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (2 trials), "Adalimumab serum trough concentration" (1 trials), "Baricitinib" (1 trials), "Cimzia" (1 trials) and "Disease activity" (1 trials). Other intervention names were less common.

The vast majority of trials in "READE" are 8 trials for "All" genders.

Currently, there are NaN active trials in "READE". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in READE, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in READE, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".